TIFFANY CRAGAN: Open Payments
NPI 1154854149 · PHILIPSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,385 in 70 payments from 15 companies in 2025. Trend: 2023 $674 · 2024 $1,219 · 2025 $1,385
Food & beverage: $1,385
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $554 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $256 |
| Otsuka America Pharmaceutical, Inc. | 7 | $146 |
| Collegium Pharmaceutical, Inc. | 5 | $87 |
| Exact Sciences Corporation | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Janssen Pharmaceuticals, Inc | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Averitas Pharma Inc. | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
Products named: RINVOQ, CAPLYTA, VRAYLAR, ABILIFY MAINTENA, Cologuard Collection Kit, Auvelity, REXULTI, MAVYRET.
Industry payments across PA — which companies pay providers there.
